A case-patient was defi ned as a patient who had undergone sclerotherapy at the clinic and subsequently had infection directly related to the site of sclerosant injection. Events were dated from the day on which the index patient had her surgical procedure. We reviewed clinic notes and infection control procedures in conjunction with the Department of Human Services of the State Government of Victoria, Australia. Specimens, where available, were collected for culture from patients by the treating clinicians. A throat swab was taken from the cosmetic surgeon. Specimens were transported and cultured by using standard methods.
During the outbreak period, 44 patients had vein sclerotherapy with 3% polidocanol at the cosmetic surgeon's clinic. In addition to the 3 patients identifi ed on admission to hospital, a fourth patient (patient B) sought treatment from her general practitioner for medical care for a postprocedure infection. All patients had procedures on day 1 or day 7 ( Figure) ; patients A and B were seen consecutively on day 1, and 2 patients were treated between patients C and D on day 7.
Patient A required surgical debridement, intravenous antimicrobial drugs, intensive care, and hyperbaric oxygen therapy. Intraoperative specimens taken from her during debridement cultured group A Streptococcus spp. Patients B, C, and D had cellulitis, but no specimens suitable for microbiologic diagnosis of cellulitis were taken for culture. Patient B was treated with oral antimicrobial agents as an outpatient. Patient C was admitted to hospital for intravenous antimicrobial therapy, and patient D showed no improvement on oral antimicrobial therapy as an outpatient and was subsequently admitted to hospital for intravenous antimicrobial agents.
Group A Streptococcus spp. was isolated from a throat swab taken on day 16 from the cosmetic surgeon. He reported no upper respiratory tract infection symptoms before the outbreak. He also reported that antiseptic skin preparation was not routinely used during the procedures; nor were gloves used. However, alcohol hand rubs were used between patients. The surgeon had not changed his infection control procedures recently and had not been aware of any infective complications previously. Environmental surface swabs taken on day 14 from 3 different areas (procedural trolley, surgical spotlight, and examination couch) in the clinic during the assessment yielded no pathogenic organisms. The infection control assessment team noted overall cleaning, disinfection, and hand hygiene to be inadequate.
Decolonization of the surgeon was performed by using rifampin 600 mg daily and amoxicillin 500 mg. every 6 hours for 10 days, during which time the surgeon suspended surgical procedures. Recommendations were made regarding infection prevention practices; these were undertaken by the surgeon.
Although soft tissue infection following sclerotherapy may be underreported, large case series have not noted this complication in the past (2,3); this fi nding suggests that any soft tissue infection following sclerotherapy should be investigated. These cases highlight the need for vigilance when considering infection control for minor procedures that take place outside of the support of hospital-based infection control services.
Soft tissue infections as complications following varicose vein sclerotherapy appear to be rare (1-3). The Australian Aethoxysklerol study reported no cellulitis in 16,804 legs injected with the sclerosing agent, and superfi cial thrombophlebitis occurred at a rate of 0.08% at 2-year review (2) . Likewise, a multicenter registry with 22 European phlebology clinics reported no cellulitis or necrotizing fasciitis in 12,173 sessions (3).
Similarly, surgical site infections with Group A Streptococcus spp. are uncommon. A multicenter survey of 72 centers worldwide reported all β-hemolytic Streptococcus spp. (including group A and group G) accounted for <5% of infections (4), while surveillance in the 1990s by Centers for Disease Control and Prevention reported <1% of all surgical wound infections was caused by group A Streptococcus spp. (5) . A Canadian study reported invasive group A Streptococcus infections following surgery in 1.1 cases per 100,000 admissions (6) . Outbreaks have been infrequently described (5, (7) (8) (9) (10) , and sources of colonization range from throat to anus and vagina.
Streptococcus suis in Humans, Thailand
To the Editor: Streptococcus suis is an important zoonotic pathogen for swine and humans. Among 33 serotypes, serotype 2 is more frequently isolated from diseased pigs than other serotypes (1). However, not all serotype 2 strains are virulent, and degree of virulence varies among strains (2) . Previous studies have reported several S. suis putative virulence factors, including the polysaccharide capsule, the muramidase-released protein, the extracellular factor, and suilysin (3) (4) (5) . Some of these factors have been used as virulence-associated markers, and the association of the factors of S. suis isolates with virulence or clinical background has been suggested in Europe (2, 5) . However, because many virulent isolates lacking these factors have also been isolated from clinical cases in Canada (6), they cannot be used as virulence markers in North America.
Recent analysis of S. suis isolates by multilocus sequence typing (MLST) suggested the association of some clonal groups with particular clinical manifestations. That is, most invasive isolates belonged to the sequence type (ST) 1 complex, while the ST27 and ST87 complexes were found to include a higher proportion of lung isolates (7). Although S. suis has been prevalent worldwide, the geographic location of the isolates used so far was mainly Europe, North America, and East Asia (7) (8) (9) . Moreover, the clonal association with virulence of S. suis has been discussed mainly on the basis of clinical and experimental data in swine (7) . In this report, to broaden understanding of the population structure of S. suis as a zoonotic agent, we characterize 20 S. suis isolates (Table) recovered from humans in Thailand in 1998-2002.
Serotyping by coagglutination tests showed that 19 of the 20 isolates
